Network origin in Elliot Goldstein first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 19 | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.
15
| Private Company | Miscellaneous Commercial Services | 15 |
| Private Company | Pharmaceuticals: Major | 7 | |
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Elliot Goldstein via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Washington University in St. Louis | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director of Finance/CFO Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | President Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of California | College/University | Graduate Degree Undergraduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
Akashi Therapeutics Inc
 Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Akashi Therapeutics Inc is a clinical stage biopharmaceutical company based in Cambridge, MA with subsidiaries in the United States. The private company has been granted orphan designation for DMD in both the US and Europe. The American company's mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi is developing a cocktail of medications with the goal of transforming Duchenne from a 100% fatal, aggressive muscle-wasting disease to a chronic, manageable condition. The application of HT-100 to DMD and other fibrotic diseases is based on pioneering work by Dr. Mark Pines at the Volcani Institute. Dosing and new patient enrollment in the phase 1b/2a clinical program have been suspended. The company was founded by leading patient organizations and biotechnology industry veterans and is managed by a seasoned team of drug development experts. The company was founded by Marc B. Blaustein, Thomas C. Wicka. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| GENVEC INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Imperial College London | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
| University of Alberta | College/University | Undergraduate Degree Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman General Counsel | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin | |
| WINDFALL GEOTEK INC. | Precious Metals | Director/Board Member | |
| McMaster University | College/University | Undergraduate Degree | |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | President | |
Neurotrophic Bioscience, Inc.
 Neurotrophic Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Neurotrophic Bioscience, Inc. develops pharmaceutical products. | Pharmaceuticals: Major | President | |
| NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
TMG Biosciences LLC
 TMG Biosciences LLC Miscellaneous Commercial ServicesCommercial Services TMG Biosciences LLC provides biosurveillance and biotechnology consulting services. It assists clients to execute biosurveillance and microbial detection/characterization programs and providing subject matter expertise on biotechnology instrumentation. The company is headquartered in Austin, TX. | Miscellaneous Commercial Services | Director/Board Member | |
| Ridgeline Therapeutics | Chairman | ||
| York University | College/University | Masters Business Admin | |
| BioHealth Care LLC | Chief Executive Officer | ||
| I-Mab Biopharma US Ltd. | Corporate Officer/Principal | ||
| GENEXINE, INC. | Biotechnology | Director/Board Member | |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX. | Miscellaneous Commercial Services | Chief Executive Officer | |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| United States | 28 |
| Canada | 16 |
| Denmark | 3 |
| United Kingdom | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 17 |
| Commercial Services | 5 |
| Non-Energy Minerals | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 174 |
| Corporate Officer/Principal | 108 |
| Director of Finance/CFO | 71 |
| Independent Dir/Board Member | 54 |
| Chief Tech/Sci/R&D Officer | 42 |
Most connected contacts
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| Kenneth Lee | 40 |
| Louis Lange | 35 |
| Cameron Durrant | 25 |
| James Sulat | 23 |
| Anthony Giovinazzo | 22 |
| Karin Hehenberger | 21 |
| Ruchita Sinha | 18 |
| Hans Schambye | 16 |
| Neil Warma | 15 |
| Warren Whitehead | 14 |
| Henrik Rasmussen | 14 |
| Eugene Williams | 13 |
| Santosh Vetticaden | 13 |
| Gad Berdugo | 13 |
- Stock Market
- Insiders
- Elliot Goldstein
- Company connections
